The biotechnology company posted revenue of $1 million in the period. The company's shares closed at $3.05. A year ago, they were trading at $5.84.
News
- GlycoMimetics: 3Q Earnings Snapshot
- Global Respiratory Virus Vaccines Market,Top key players @ CSL Limited, Bharat Biotech, Sanofi ...
Top key players @ CSL Limited, Bharat Biotech, Sanofi, AstraZeneca, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., ... 1604 W San Antonio,.
- Global Cancer mTOR Inhibitors Market,Top key players @ Abraxis BioScience, Adimab, Celgene ...
Top key players @ Abraxis BioScience, Adimab, Celgene Corporation, Celator Pharmaceuticals, Eli Lilly, Exelixis, ... 1604 W San Antonio,. TX 78249.
- Business Is Booming For San Antonio's Virus-Killing Robot Company
Texas Biomed in San Antonio successfully tested the robot against the virus in April of this year. The robot is regulated by the Environmental Protection ...
- FDA panel reviews 1st new Alzheimer's drug in 2 decades
It's a biotech medicine made from living cells, and such drugs are very expensive. No price estimate has been announced for the drug, which is given ...